| Jessica Dawn Klein, CNP | |
|
1000 E 23rd St, Sioux Falls, SD 57105-2108 | |
| (605) 322-3035 | |
| Not Available |
| Full Name | Jessica Dawn Klein |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 1000 E 23rd St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225300312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | C-APN.0001230-C-NP (Colorado) | Secondary |
| 363L00000X | Nurse Practitioner | CP000688 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uch-memorial Health System | Colorado springs, CO | Hospital |
| Uchealth Grandview Hospital | Colorado springs, CO | Hospital |
| Uchealth Pikes Peak Regional Hospital | Woodland park, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Poudre Valley Medical Group Llc | 9638208549 | 1605 |
News Archive
Under the agreement, Dowpharma's proprietary MeO-DOTA bifunctional chelant technology will be used to radiolabel Cytogen's prostate-specific membrane antigen (PSMA) antibody with a therapeutic radionuclide. PSMA is a protein highly expressed on the surface of prostate cancer cells and the neovasculature of many solid tumors.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
Reproductive Medicine Associates of New York is proud to announce their partnership with Mount Sinai Medical Center on a study that will examine the long-term effects of PCOS on children born to mothers who have been diagnosed with this condition.
To decide whether a new medical technology is cost effective, researchers often "compare a new technology's incremental cost-effectiveness ratio or ICER to a threshold that is some multiple of a country or income group's GDP per capita, per WHO convention," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the CGD's "Global Health Policy" blog
› Verified 4 days ago
| Entity Name | Poudre Valley Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
Under the agreement, Dowpharma's proprietary MeO-DOTA bifunctional chelant technology will be used to radiolabel Cytogen's prostate-specific membrane antigen (PSMA) antibody with a therapeutic radionuclide. PSMA is a protein highly expressed on the surface of prostate cancer cells and the neovasculature of many solid tumors.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
Reproductive Medicine Associates of New York is proud to announce their partnership with Mount Sinai Medical Center on a study that will examine the long-term effects of PCOS on children born to mothers who have been diagnosed with this condition.
To decide whether a new medical technology is cost effective, researchers often "compare a new technology's incremental cost-effectiveness ratio or ICER to a threshold that is some multiple of a country or income group's GDP per capita, per WHO convention," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the CGD's "Global Health Policy" blog
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Dawn Klein, CNP 1000 E 23rd St, Sioux Falls, SD 57105-2108 Ph: (605) 322-3035 | Jessica Dawn Klein, CNP 1000 E 23rd St, Sioux Falls, SD 57105-2108 Ph: (605) 322-3035 |
News Archive
Under the agreement, Dowpharma's proprietary MeO-DOTA bifunctional chelant technology will be used to radiolabel Cytogen's prostate-specific membrane antigen (PSMA) antibody with a therapeutic radionuclide. PSMA is a protein highly expressed on the surface of prostate cancer cells and the neovasculature of many solid tumors.
Oncolytics Biotech Inc. announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN(R) for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham.
Reproductive Medicine Associates of New York is proud to announce their partnership with Mount Sinai Medical Center on a study that will examine the long-term effects of PCOS on children born to mothers who have been diagnosed with this condition.
To decide whether a new medical technology is cost effective, researchers often "compare a new technology's incremental cost-effectiveness ratio or ICER to a threshold that is some multiple of a country or income group's GDP per capita, per WHO convention," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the CGD's "Global Health Policy" blog
› Verified 4 days ago
Paul Stamp, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 S Cliff Ave, Suite 610, Sioux Falls, SD 57105 Phone: 605-322-8860 | |
Lien Lieve Swieringa, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2601 S Ellis Rd, Sioux Falls, SD 57106 Phone: 605-312-3000 | |
Kaitlyn Sarah Isaacson, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6110 S Minnesota Ave, Sioux Falls, SD 57108 Phone: 605-328-5800 | |
Mariah Schurman, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 W 18th St, Sioux Falls, SD 57105 Phone: 605-312-2100 | |
Dillon Matthew Hansen, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 S Cliff Ave # 2, Sioux Falls, SD 57105 Phone: 605-322-7020 | |
Chelsey Zondervan, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1309 W 17th St, Sioux Falls, SD 57104 Phone: 605-328-8000 Fax: 605-328-8001 | |
Mrs. Donna Lynn Sebesta, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1900 S Grandview Ave, Sioux Falls, SD 57103 Phone: 605-371-3436 |